InterCure to Participate in Cowen 5th Annual Cannabis Conference
09 December 2022 - 1:30AM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc)("InterCure" or the “Company”) today announced that
Alexander Rabinovitch, CEO of InterCure, will participate in Cowen
5th Annual Cannabis Conference, taking place December 8th, 2022.
Mr. Rabinovitch will take part in the industry
leaders panel on Thursday, December 8th, 2022 at 9:30 AM
EST, and will be available for 1 on 1 sessions by appointment
only.
About InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its market leading distribution
network, best in class international partnerships and a high-margin
vertically integrated "seed-to-sale" model to lead the fastest
growing cannabis global market outside of North America.
For more information, visit:
http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief Financial
Officeramos@intercure.co
Intercure (TSX:INCR.U)
Historical Stock Chart
From May 2024 to Jul 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Jul 2023 to Jul 2024